Retatrutide (5mg)

Retatrutide 5mg is a lyophilized research peptide supplied in a 5-milligram vial for laboratory investigation. Retatrutide is known as a triple agonist, targeting the GLP-1, GIP, and glucagon receptors, which are pathways involved in metabolic regulation and energy balance.

In research settings, it is studied for its potential effects on:

• Metabolic signaling
• Glucose regulation pathways
• Appetite and satiety mechanisms
• Body weight and energy expenditure models

A 5mg presentation is typically used in controlled research protocols where lower total peptide quantities are required per study phase or experimental model.